
4D Molecular Therapeutics Inc
NASDAQ:FDMT

Intrinsic Value
The intrinsic value of one
FDMT
stock under the Base Case scenario is
0.69
USD.
Compared to the current market price of 6.63 USD,
4D Molecular Therapeutics Inc
is
Overvalued by 90%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
4D Molecular Therapeutics Inc
Loading...
Fundamental Analysis


Revenue & Expenses Breakdown
4D Molecular Therapeutics Inc
Balance Sheet Decomposition
4D Molecular Therapeutics Inc
Current Assets | 332.6m |
Cash & Short-Term Investments | 321.4m |
Other Current Assets | 11.1m |
Non-Current Assets | 183.2m |
Long-Term Investments | 137m |
PP&E | 39.1m |
Other Non-Current Assets | 7m |
Free Cash Flow Analysis
4D Molecular Therapeutics Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
4D Molecular Therapeutics Inc
Revenue
|
23k
USD
|
Operating Expenses
|
-203.3m
USD
|
Operating Income
|
-203.3m
USD
|
Other Expenses
|
26.9m
USD
|
Net Income
|
-176.4m
USD
|
FDMT Profitability Score
Profitability Due Diligence
4D Molecular Therapeutics Inc's profitability score is 20/100. The higher the profitability score, the more profitable the company is.

Score
4D Molecular Therapeutics Inc's profitability score is 20/100. The higher the profitability score, the more profitable the company is.
FDMT Solvency Score
Solvency Due Diligence
4D Molecular Therapeutics Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Score
4D Molecular Therapeutics Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
FDMT Price Targets Summary
4D Molecular Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
FDMT
is 30.15 USD
with a low forecast of 10.1 USD and a high forecast of 46.2 USD.
Dividends
Current shareholder yield for FDMT is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
FDMT
stock under the Base Case scenario is
0.69
USD.
Compared to the current market price of 6.63 USD,
4D Molecular Therapeutics Inc
is
Overvalued by 90%.